Volume 11, Number 1—January 2005
Emergent Strain of Human Adenovirus Endemic in Iowa
Highlight and copy the desired format.
|EID||Gray GC, Setterquist SF, Jirsa SJ, DesJardin LE, Erdman DD. Emergent Strain of Human Adenovirus Endemic in Iowa. Emerg Infect Dis. 2005;11(1):127-128. https://dx.doi.org/10.3201/eid1101.040490|
|AMA||Gray GC, Setterquist SF, Jirsa SJ, et al. Emergent Strain of Human Adenovirus Endemic in Iowa. Emerging Infectious Diseases. 2005;11(1):127-128. doi:10.3201/eid1101.040490.|
|APA||Gray, G. C., Setterquist, S. F., Jirsa, S. J., DesJardin, L. E., & Erdman, D. D. (2005). Emergent Strain of Human Adenovirus Endemic in Iowa. Emerging Infectious Diseases, 11(1), 127-128. https://dx.doi.org/10.3201/eid1101.040490.|
We evaluated 76 adenovirus type 7 (Ad7) isolates collected in Iowa from 1992 to 2002 and found that genome type Ad7d2 became increasingly prevalent. By 2002, it had supplanted all other Ad7 genome types. The association of Ad7d2 with severe illness and death calls for heightened public health concern.
Human adenoviruses are the cause of a wide spectrum acute and chronic diseases. The associations of adenovirus with keratoconjunctivitis, upper respiratory tract infections, pneumonia, gastroenteritis, cystitis, and encephalitis have long been recognized. Recently, molecular methods have shown adenoviruses to be associated with bronchopulmonary dysplasia (1), chronic obstructive pulmonary disease (2), and mycocarditis (3). Adenovirus infections cause severe illness and death in immunocompromised persons, particularly bone marrow transplant recipients (4–6).
In 2002, Erdman et al. (7) reported that 2 emergent genome types of adenovirus type 7 (Ad7) had recently been detected in North American populations. From restriction enzyme studies of 166 archived specimens, the available data suggested that Ad7d2 and Ad7h first appeared in North America in 1993 and 1998, respectively. Both genome types had been associated with epidemics, severe illness, and deaths in populations outside the United States. Since Ad7d2 has been associated with 3 military and 3 civilian epidemics and at least 19 deaths in the United States since 1993, the 2002 report voiced concern regarding a shift in the prevalence of U.S. adenovirus strains and the need to increase surveillance for adenoviral disease. We present a retrospective study of Ad7 isolates in Iowa.
By using a previously described DNA restriction analysis procedure (7), we studied 76 archived adenovirus isolates collected among influenzalike-illness surveillance sites across Iowa from 1992 to 2002.
Among the 76 isolates, 40 (53%) were Ad7d2, and 6 (8%) were Ad7h (Figure). The first Ad7d2 specimen was isolated in March 1994 from a child living in south-central Iowa. The first Ad7h specimen was isolated in November 1993 from a child living in north-central Iowa. The latter specimen is the earliest Ad7h detected in North America.
Ad7d2 caused illness among patients in Iowa ranging in age from 3 months to 49 years. Of the patients, 75% were male (cause of overrepresentation is unknown). Although the clinical details are sparse, a number of patients were thought to have influenza or were diagnosed with respiratory distress syndrome. At least 4 children from an Ad7d2 October 2000 epidemic at a long-term care facility in Des Moines, Iowa, died. Ad7d2 isolates were obtained from 12 different sites in Iowa. Ad7h was detected in 4 Iowa counties.
Beginning in 1994, Ad7d2 became increasingly more prevalent across Iowa, displacing Ad7b, the predominant genome type circulating in the United States since the early 1970s (8). In 2002, data suggest that Ad7d2 supplanted all other Ad7 genome types (9 of 9 Ad7 isolates were A7d2) (Figure).
Ad7d2 and Ad7h have only recently been recognized. Ad7d2 was first detected in Israel in 1992; beginning in 1995, it was associated with epidemics of unusually severe respiratory disease with high fevers among children in Japan (9,10). Ad7h was first detected in South America in 1986; since then it has supplanted the previous most prevalent genome type, Ad7c, in Chile, Uruguay, Argentina, and possibly other countries (11). Ad7h has caused pediatric respiratory epidemics, and infected children had longer hospitalizations, had higher temperatures, and required more supplemental oxygen (12). In at least 1 study, up to 94% of adenovirus deaths were attributed to Ad7h (11).
Whether these strains are truly more virulent or whether they better evade the host’s immune system is a matter for future study. What does seem to be clear is that a simple mutation (Ad7d2) (9) or recombination (Ad7h) (13) may generate new adenovirus strains that could result in more epidemics and higher death rates. These strains may then quickly migrate to new areas and cause more epidemics.
Current U.S. surveillance for adenovirus is passive and incomplete. The number of immunocompromised patients in the United States is increasing, and they, in addition to young children, may be at increased risk for severe disease from emergent adenovirus strains. Developing molecular typing strategies for emerging Ad strains seems prudent, as does improving local and national surveillance for adenovirus illness. Considering adenovirus to be a potential nosocomial pathogen seems wise, and researchers should seek to identify effective antiviral therapy for outbreak interventions. These actions will help public health officials better understand the changing epidemiology of adenovirus infections. Because of increased adenovirus morbidity (14,15), the U.S. Department of Defense recently contracted to again produce Ad4 and Ad7 vaccines for military trainees. If civilian populations were identified to be at high risk for serious Ad4 or Ad7 disease, they might also benefit from these vaccines.
Dr. Gray is a public health physician and professor of epidemiology in the Department of Epidemiology, at the University of Iowa College of Public Health. He directs the college’s Center for Emerging Infectious Diseases. He conducts epidemiologic studies of human adenovirus, human metapneumovirus, and zoonotic influenza infections.
This study was funded by the University of Iowa. A preliminary report of this work was presented at the International Conference on Emerging Infectious Diseases held in Atlanta, Georgia, during February 29 through March 3, 2004.
- Couroucli XI, Welty SE, Ramsay PL, Wearden ME, Fuentes-Garcia FJ, Ni J, Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res. 2000;47:225–32.
- Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med. 2001;164:S71–5.
- Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466–72.
- Baldwin A, Kingman H, Darville M, Foot AB, Grier D, Cornish JM, Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 2000;26:1333–8.
- Runde V, Ross S, Trenschel R, Lagemann E, Basu O, Renzing-Kohler K, Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant. 2001;28:51–7.
- Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 2002;100:1619–27.
- Erdman DD, Xu W, Gerber SI, Gray GC, Schnurr D, Kajon AE, Molecular epidemiology of adenovirus type 7 in the United States, 1966–2000. Emerg Infect Dis. 2002;8:269–77.
- Adrian T, Becker M, Hierholzer JC, Wigand R. Molecular epidemiology and restriction site mapping of adenovirus 7 genome types. Arch Virol. 1989;106:73–84.
- Noda M, Yoshida T, Sakaguchi T, Ikeda Y, Yamaoka K, Ogino T. Molecular and epidemiological analyses of human adenovirus type 7 strains isolated from the 1995 nationwide outbreak in Japan. J Clin Microbiol. 2002;40:140–5.
- Yamadera S, Yamashita K, Akatsuka M, Kato N, Inouye S. Trend of adenovirus type 7 infection, an emerging disease in Japan. A report of the National Epidemiological Surveillance of Infectious Agents in Japan. Jpn J Med Sci Biol. 1998;51:43–51.
- Kajon AE, Mistchenko AS, Videla C, Hortal M, Wadell G, Avendano LF. Molecular epidemiology of adenovirus acute lower respiratory infections of children in the south cone of South America (1991–1994). J Med Virol. 1996;48:151–6.
- Larranaga C, Kajon A, Villagra E, Avendano LF. Adenovirus surveillance on children hospitalized for acute lower respiratory infections in Chile (1988–1996). J Med Virol. 2000;60:342–6.
- Kajon AE, Wadell G. Sequence analysis of the E3 region and fiber gene of human adenovirus genome type 7h. Virology. 1996;215:190–6.
- Gray GC, Goswami PR, Malasig MD, Hawksworth AW, Trump DH, Ryan MA, Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Clin Infect Dis. 2000;31:663–70.
- Ryan MAG, Gray GC, Smith B, McKeehan JA, Hawksworth AW, Malasig MD. Large epidemic of respiratory illness from adenovirus 7 and 3 among healthy young adults. Clin Infect Dis. 2002;34:577–82.
- Figure. Number of adenovirus (Ad) isolates collected in Iowa during influenzalike-illness surveillance by genome type and year.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Gregory C. Gray, University of Iowa College of Public Health, 200 Hawkins Dr, C21K GH, Iowa City, IA 52242, USA; fax: 319-384-5004
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 14, 2011
- Page last updated: April 14, 2011
- Page last reviewed: April 14, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)